Taysha Gene Therapies

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell TSHA and other ETFs, options, and stocks.

About TSHA

Taysha Gene Therapies, Inc. is a clinical-stage biotechnology company, which engages in the development and commercialization of adeno-associated viruses (AAV) based gene therapies for the treatment of monogenic diseases of the central nervous system. It also develops multiple gene therapy platforms which include AAV9 Discovery, Novel Capsid, and AAV Redosing.

CEO

Sean P. Nolan

CEOSean P. Nolan

Employees

Employees73

Headquarters

Dallas, Texas

HeadquartersDallas, Texas

Founded

2019

Founded2019

Employees

Employees73

TSHA Key Statistics

Market cap

613.29M

Market cap613.29M

Price-Earnings ratio

-6.47

Price-Earnings ratio-6.47

Dividend yield

—

Dividend yield—

Average volume

3.23M

Average volume3.23M

High today

$2.47

High today$2.47

Low today

$2.25

Low today$2.25

Open price

$2.36

Open price$2.36

Volume

2.68M

Volume2.68M

52 Week high

$3.31

52 Week high$3.31

52 Week low

$1.05

52 Week low$1.05

Analyst ratings

100%

of 11 ratings

Buy

100%

Hold

Sell

People also own

Based on the portfolios of people who own TSHA. This list is generated using Robinhood data, and it’s not a recommendation.